This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

24-26 February 2020
The Westin Miyako Kyoto,
Kyoto, Japan

THE ONLY EVENT IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN THERAPIES, ADCS, BISPECIFICS AND IMMUNO-ONCOLOGY

World-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track your next-generation therapeutics towards commercial success

New Report Available!

Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics

NEW TECHNOLOGIES, R&D ADVANCES AND CLINICAL DATA TO HELP YOU FAST-TRACK NEXT-GENERATION THERAPEUTICS TO MARKET

Novel Approaches to Accelerate Therapeutic Development
  • Sally Ward’s Research on Targeting Intracellular Trafficking Pathways for the Design of Therapeutics
  • Shohei Koide’s Advances in Novel Therapeutics Based on Synthetic Binding Proteins
  • Lava Therapeutics’ Novel Bispecific γδ-T cell Engagers for the Treatment of Cancer
  • Chugai’s Novel Antibody Engineering to Improve Therapeutic Index of Antibody Targeting Solid Tumors
  • Takeda’s Vision for Antibody Drug Discovery: An Overview of Programs and Progress
  • Koji Tamada’s Prime CAR Technology, a Novel Platform of T cell Therapy Against Solid Tumors
Scientific Case Studies and New Data
  • Invenra, Amgen, Argenx, Xencor, Immatics and AbbVie Case Studies and New Data
  • Eisai’s Progress on the Development of a Novel Anti-Tau Antibody
  • NBE-Therapeutics’ Update on NBE-002, An Anthracycline-based Immune-stimulatory Antibody Drug Conjugate
  • Sai Reddy’s Data on How Deep Learning Enables Therapeutic Antibody Optimization in Mammalian Cells
  • Genentech’s MerTK Blockade Which Enhances Antitumor Immunity
  • Dainippon Sumitomo’s Antibody Intracellular Activated Drug Conjugate (AiADC) As a Novel ADC Technology
New This Year!
  • Workshop on Engineering Strategies for TCR and CAR T Cell Therapies
  • World-Renowned Academic and Industry Keynotes
  • More Confirmed Speakers from Leading US and European Antibody Companies
  • More Science and Data - 80% of Speakers Are New This Year
  • Kyoto, Japan Location – Voted in Many Surveys As One of the Top Cities in the World to Visit
  • Expanded Exhibit and Poster Sessions

Get Global Recognition of Your Work by Presenting a Poster


  1. FOCUSED DISCUSSIONS: Posters offer the opportunity to engage with others also interested in the same subject and application as yourself which could potentially lead to future collaboration. 
  2. RECEIVE IMPARTIAL CRITIQUES: An insightful, impartial discussion of your work by a peer can often provide ideas for improving your work downstream.
  3. SHARPEN YOUR PRESENTATION SKILLS: Presenting a poster enables you to explain a concept in different ways to see which method is most well received and practice your visual and oral presentations.
  4. HONE YOUR IDEAS: A poster is ideal for early stages of the research, when you may not have much more than an idea, and you stand to benefit a lot from discussing your idea with other researchers from the same field
Deadline to Submit a Poster is 24 January 2020

Meet the Esteemed Scientific Advisory Board

  • Tomoyuki Igawa, Ph.D., CEO and Research Head, Chugai Pharmabody Research Pte. Ltd., Singapore
  • Qing Li, Ph.D., Scientist I, Medimmune, USA
  • Sai Reddy, Ph.D., Assistant Professor,  ETH Zurich, Switzerland
  • Jijie Gu, Ph.D., Chief Scientific Officer and Executive Vice President,
    WuXi Biologics, China
  • Chengbin Wu, Ph.D., Chief Executive Officer, Shanghai EpimAb Biotherapeutics Inc., China
  • Yong-Sung Kim, Ph.D., Professor, Departments of Molecular Science and Technology, and Applied Chemistry and Biological Engineering, Ajou University, South Korea
  • Karthik Viswanathan, Director, Research, Visterra, Inc., USA
  • Andrew Bradbury, M.D., Ph.D., Chief Scientific Officer, Specifica, USA

CONNECT WITH KEY BUYERS AT Antibody Asia 2020 in Kyoto


Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Kristin Skahan: KSkahan@knect365lifesciences.com | +1-857-504-6730 


Get the latest event updates

Sign up to get the latest event updates and information.